Growing community of inventors

Belmont, MA, United States of America

Brian Addison Dechristopher

Average Co-Inventor Count = 12.48

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Brian Addison DechristopherPhilipp Grosche (2 patents)Brian Addison DechristopherAlec Nathanson Flyer (2 patents)Brian Addison DechristopherLauren Gilchrist Monovich (2 patents)Brian Addison DechristopherRui Zheng (2 patents)Brian Addison DechristopherTajesh Jayprakash Patel (2 patents)Brian Addison DechristopherAndrei Alexandrovich Golosov (2 patents)Brian Addison DechristopherJustin Yik Ching Mao (2 patents)Brian Addison DechristopherLiansheng Su (2 patents)Brian Addison DechristopherEugene Yuejin Liu (2 patents)Brian Addison DechristopherKarin Briner (2 patents)Brian Addison DechristopherLihua Yang (2 patents)Brian Addison DechristopherCarina Cristina Sanchez (1 patent)Brian Addison DechristopherBrian Addison Dechristopher (2 patents)Philipp GroschePhilipp Grosche (16 patents)Alec Nathanson FlyerAlec Nathanson Flyer (13 patents)Lauren Gilchrist MonovichLauren Gilchrist Monovich (12 patents)Rui ZhengRui Zheng (11 patents)Tajesh Jayprakash PatelTajesh Jayprakash Patel (9 patents)Andrei Alexandrovich GolosovAndrei Alexandrovich Golosov (9 patents)Justin Yik Ching MaoJustin Yik Ching Mao (5 patents)Liansheng SuLiansheng Su (4 patents)Eugene Yuejin LiuEugene Yuejin Liu (3 patents)Karin BrinerKarin Briner (2 patents)Lihua YangLihua Yang (2 patents)Carina Cristina SanchezCarina Cristina Sanchez (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (2 from 3,923 patents)


2 patents:

1. 11813306 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders

2. 11026993 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…